Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines
Fexofendine 120 mg, Montelukast 10 mg, For Hospital
₹ 149/Stripe
Usage/Application
Hospital
Packaging Type
Alu Alu
Brand Name
ATMOKAST-FX
Also gives
PCD Pharma
Packaging Size
10X1X10
Composition
Antiasthmatic
Deals in
PCD Pharma
Form
Tablets
Country of Origin
Made in India
Availability
In Stock
Alvizia Healthcare (A Division of Ben Hadded Pharma Pvt.Ltd.), a PCD pharma an ISO 9001:2015 Certified Company, established in Chandigarh, We are one of the prominent suppliers, distributors, wholesalers and traders of finest quality Pharmaceutical Drugs. We offer a wide range of products including drugs, nutrition supplements and Ayurvedic products. We deal with Tablets, Capsules, Soft-gels, Liquids, Dry Syrups, Protein Powders, Injections, Drops, Sachets, Ointments, Lotions, Shampoo and Oils.
Find products similar to Fexofendine 120 Mg, Montelukast 10 Mg, For Hospital
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
01-07-2017
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
May 2022
GST
04AANFB8849H2Z2
Established in the year of 2012, We “Alvizia Healthcare A Division of Benhadded Pharma Pvt Ltd” An ISO 9001:2015 Certified Company are Wholesale Trader of an Pharmaceutical Tablets, Pharmaceutical Syrup, Pharmaceutical Capsules, Pharmaceutical Injections, Pharmaceutical Ointment, Protein Powder, Medicated Soap, Nasal Drops, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to our Mr. Rana, whose continual backing and direction have been useful to us for attaining exponential development in the current market.
